API reference

Oxcarbazepine

CAS number
28721-07-5
Molecular formula
C15H12N2O2
Molecular weight
252.27 g/mol
Oxcarbazepine — 2D structure
2D structure (PubChem)

About this molecule

Oxcarbazepine is an anti-epileptic medication used in the treatment of partial onset seizures that was first approved for use in the United States in 2000. It is a structural derivative of [carbamazepine] and exerts a majority of its activity via a pharmacologically active metabolite, MHD, which exists as a racemate in the blood - a pro-drug of the more active (S)-enantiomer is also marketed as a separate anti-epileptic under the name [eslicarbazepine]. Compared to other anti-epileptic drugs, which are generally metabolized via the cytochrome P450 system, oxcarbazepine has a reduced propensity for involvement in drug-drug interactions owing to its primarily reductive metabolism.

Source: DrugBank, via PubChem.

Identifiers

IUPAC name
5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
InChIKey
CTRLABGOLIVAIY-UHFFFAOYSA-N
SMILES
C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
PubChem CID
34312

Also known as

Trileptal · Oxcarbamazepine · Oxcarbazepina · Oxcarbazepinum · Oxtellar XR · KIN-493 · OCBZ · SPN-804

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com